The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD

Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: BGF Inhalation Aerosphere;   Drug: GFF Inhalation Aerosphere Sponsors:   ShiYue Li;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials